Cargando…

Increased Serum Cystatin C in Early Parkinson's Disease with Objective Sleep Disturbances

BACKGROUND: Sleep disturbance is one of the major non-motor symptoms which cause the disability of Parkinson's disease (PD) patients. Cystatin C (CysC) is a more sensitive biomarker than serum creatinine or estimated glomerular filtration rate. Previous studies have reported altered CysC levels...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiong, Kang-Ping, Dai, Yong-Ping, Chen, Jing, Xu, Jin-Min, Wang, Yi, Feng, Ping, You, Shou-Jiang, Liu, Chun-Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5912055/
https://www.ncbi.nlm.nih.gov/pubmed/29664049
http://dx.doi.org/10.4103/0366-6999.229902
_version_ 1783316327661830144
author Xiong, Kang-Ping
Dai, Yong-Ping
Chen, Jing
Xu, Jin-Min
Wang, Yi
Feng, Ping
You, Shou-Jiang
Liu, Chun-Feng
author_facet Xiong, Kang-Ping
Dai, Yong-Ping
Chen, Jing
Xu, Jin-Min
Wang, Yi
Feng, Ping
You, Shou-Jiang
Liu, Chun-Feng
author_sort Xiong, Kang-Ping
collection PubMed
description BACKGROUND: Sleep disturbance is one of the major non-motor symptoms which cause the disability of Parkinson's disease (PD) patients. Cystatin C (CysC) is a more sensitive biomarker than serum creatinine or estimated glomerular filtration rate. Previous studies have reported altered CysC levels in neurodegenerative disorders and sleep disorders. This study aimed to explore the correlations of serum CysC levels and objective sleep disturbances in early PD. METHODS: We recruited 106 early PD patients and 146 age- and sex-matched controls. All participants underwent clinical investigation and video-polysomnography. Sleep parameters and serum levels of CysC were measured. Then, we investigated the relationships between CysC and clinical variables and objective sleep disturbances in early PD patients. RESULTS: The mean serum level of CysC was significantly higher in patients with early PD (1.03 ± 0.19 mg/L) compared to controls (0.96 ± 0.15 mg/L, P = 0.009). There were significantly positive correlations between serum CysC levels and age (r = 0.334, P < 0.001), gender (r = 0.264, P = 0.013), and creatinine levels (r = 0.302, P = 0.018) in early PD patients. Increased serum CysC levels in early PD patients were significantly associated with higher apnea and hypopnea index (AHI) (r = 0.231, P = 0.017), especially hypopnea index (r = 0.333, P < 0.001). In early PD patients, elevated serum CysC levels were positively correlated with oxygen desaturation index (r = 0.223, P = 0.021), percentage of time spent at oxygen saturation (SaO(2)) <90% (r = 0.644, P < 0.001), arousal with respiratory event during sleep (r = 0.247, P = 0.013). On the contrary, the elevated serum CysC levels were negatively correlated with mean and minimal SaO(2) (r = −0.323, −0.315, both P = 0.001) in PD patients. CONCLUSIONS: The level of serum CysC was higher in early PD patients. PD patients with elevated serum CysC levels had more respiratory events and more severe oxygen desaturation. Therefore, the serum CysC levels may predict the severities of sleep-disordered breathing problems in early PD patients.
format Online
Article
Text
id pubmed-5912055
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-59120552018-05-03 Increased Serum Cystatin C in Early Parkinson's Disease with Objective Sleep Disturbances Xiong, Kang-Ping Dai, Yong-Ping Chen, Jing Xu, Jin-Min Wang, Yi Feng, Ping You, Shou-Jiang Liu, Chun-Feng Chin Med J (Engl) Original Article BACKGROUND: Sleep disturbance is one of the major non-motor symptoms which cause the disability of Parkinson's disease (PD) patients. Cystatin C (CysC) is a more sensitive biomarker than serum creatinine or estimated glomerular filtration rate. Previous studies have reported altered CysC levels in neurodegenerative disorders and sleep disorders. This study aimed to explore the correlations of serum CysC levels and objective sleep disturbances in early PD. METHODS: We recruited 106 early PD patients and 146 age- and sex-matched controls. All participants underwent clinical investigation and video-polysomnography. Sleep parameters and serum levels of CysC were measured. Then, we investigated the relationships between CysC and clinical variables and objective sleep disturbances in early PD patients. RESULTS: The mean serum level of CysC was significantly higher in patients with early PD (1.03 ± 0.19 mg/L) compared to controls (0.96 ± 0.15 mg/L, P = 0.009). There were significantly positive correlations between serum CysC levels and age (r = 0.334, P < 0.001), gender (r = 0.264, P = 0.013), and creatinine levels (r = 0.302, P = 0.018) in early PD patients. Increased serum CysC levels in early PD patients were significantly associated with higher apnea and hypopnea index (AHI) (r = 0.231, P = 0.017), especially hypopnea index (r = 0.333, P < 0.001). In early PD patients, elevated serum CysC levels were positively correlated with oxygen desaturation index (r = 0.223, P = 0.021), percentage of time spent at oxygen saturation (SaO(2)) <90% (r = 0.644, P < 0.001), arousal with respiratory event during sleep (r = 0.247, P = 0.013). On the contrary, the elevated serum CysC levels were negatively correlated with mean and minimal SaO(2) (r = −0.323, −0.315, both P = 0.001) in PD patients. CONCLUSIONS: The level of serum CysC was higher in early PD patients. PD patients with elevated serum CysC levels had more respiratory events and more severe oxygen desaturation. Therefore, the serum CysC levels may predict the severities of sleep-disordered breathing problems in early PD patients. Medknow Publications & Media Pvt Ltd 2018-04-20 /pmc/articles/PMC5912055/ /pubmed/29664049 http://dx.doi.org/10.4103/0366-6999.229902 Text en Copyright: © 2018 Chinese Medical Journal http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Xiong, Kang-Ping
Dai, Yong-Ping
Chen, Jing
Xu, Jin-Min
Wang, Yi
Feng, Ping
You, Shou-Jiang
Liu, Chun-Feng
Increased Serum Cystatin C in Early Parkinson's Disease with Objective Sleep Disturbances
title Increased Serum Cystatin C in Early Parkinson's Disease with Objective Sleep Disturbances
title_full Increased Serum Cystatin C in Early Parkinson's Disease with Objective Sleep Disturbances
title_fullStr Increased Serum Cystatin C in Early Parkinson's Disease with Objective Sleep Disturbances
title_full_unstemmed Increased Serum Cystatin C in Early Parkinson's Disease with Objective Sleep Disturbances
title_short Increased Serum Cystatin C in Early Parkinson's Disease with Objective Sleep Disturbances
title_sort increased serum cystatin c in early parkinson's disease with objective sleep disturbances
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5912055/
https://www.ncbi.nlm.nih.gov/pubmed/29664049
http://dx.doi.org/10.4103/0366-6999.229902
work_keys_str_mv AT xiongkangping increasedserumcystatincinearlyparkinsonsdiseasewithobjectivesleepdisturbances
AT daiyongping increasedserumcystatincinearlyparkinsonsdiseasewithobjectivesleepdisturbances
AT chenjing increasedserumcystatincinearlyparkinsonsdiseasewithobjectivesleepdisturbances
AT xujinmin increasedserumcystatincinearlyparkinsonsdiseasewithobjectivesleepdisturbances
AT wangyi increasedserumcystatincinearlyparkinsonsdiseasewithobjectivesleepdisturbances
AT fengping increasedserumcystatincinearlyparkinsonsdiseasewithobjectivesleepdisturbances
AT youshoujiang increasedserumcystatincinearlyparkinsonsdiseasewithobjectivesleepdisturbances
AT liuchunfeng increasedserumcystatincinearlyparkinsonsdiseasewithobjectivesleepdisturbances